In vivo chemical sensors for intensive-care monitoring.
There is a need for rapid assessment of a patient's biochemical status during intensive care so that therapies may be optimised. Chemical sensors for key species have the potential to allow continuous in vivo monitoring, and some progress is being made with certain sensors. Gases, ions and certain catabolites such as glucose and urea may be measured with devices based on mass spectrometric, electrochemical or optical principles. The physical form, and size of sensors must be matched to the measurement site, which can include the airway, the intravascular space, tissue and the skin surface. Electrochemical sensors for measurement of O2, pH and glucose have been the most widely used to date, although fibre-optic devices are currently attracting considerable interest. Invasive sensors still suffer from the problem of poor biocompatibility, particularly devices used in arteries and veins. Noninvasive methods may be successful in certain circumstances and in some patient groups, but peripheral measurements are often significantly influenced by circulatory phenomena such as shock. Further research is required if these limitations of both invasive and noninvasive sensors are to be overcome and continuous chemical monitoring is to be established as a routine clinical technique.
Department of Biomedical Engineering & Medical Physics, University of Keele, Hospital Centre, Stoke-on-Trent, Staffs, UK.
P
P
Rolfe
D001672:Biocompatible Materials; D015374:Biosensing Techniques; D001774:Blood Chemical Analysis / Q000295:instrumentation; D002624:Chemistry, Clinical / Q000295:instrumentation*; D003422:Critical Care / Q000379:methods*; D006801:Humans
D001672:Biocompatible Materials